Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRoswell Park Cancer Institute
About this trial
This trial studies photoacoustic imaging of the breast in patients with breast cancer and healthy subjects. Dense breasts typically reduce the sensitivity of a mammography and also is associated with a higher risk of breast cancer. Photoacoustic tomography combines light and sound to provide more information about breast tissue.
Eligibility criteria
Qualifiers
Women with clinically suspicious or confirmed breast cancer masses (that have not been surgically removed) and will/have already undergo/undergone breast magnetic resonance imaging (MRI).
Disqualifiers
Pregnant women (there are no known risks to these procedures, but any unforeseen risks are as yet undetermined, so pregnant women will be excluded by means of a verbal confirmation at time of screening).
Women who have had breast implants in the previous 6 months.
Women who have had lumpectomy
Adults unable to consent.
Trial design
Treatments tested in this trial
- Photoacoustic Imaging
Treatment groups
400 Participants
are divided into 1 treatment groupSponsors and collaborators
Roswell Park Cancer Institute
Lead sponsor
Susan G. Komen Breast Cancer Foundation
Collaborator
Source ClinicalTrials.gov